Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2021-11-05 00:00:00 ET · period of report 2021-10-01 · accession 0001209191-21-063222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-05 | 2021-10-01+ | CPIX | KAZIMI A J | COB, CEO, Dir, 10% | P - Purchase | $2.72 | +315 | 5.77M | +0.0% | +$856.95 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | P | A | 15 | $2.69 | 5,769,474 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 2 | Common | Common Stock | 2021-10-04 | P | A | 15 | $2.87 | 5,769,489 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 3 | Common | Common Stock | 2021-10-05 | P | A | 15 | $2.82 | 5,769,504 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 4 | Common | Common Stock | 2021-10-06 | P | A | 15 | $2.76 | 5,769,519 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 5 | Common | Common Stock | 2021-10-07 | P | A | 15 | $2.76 | 5,769,534 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 6 | Common | Common Stock | 2021-10-08 | P | A | 15 | $2.84 | 5,769,549 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 7 | Common | Common Stock | 2021-10-11 | P | A | 15 | $2.73 | 5,769,564 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 8 | Common | Common Stock | 2021-10-12 | P | A | 15 | $2.71 | 5,769,579 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 9 | Common | Common Stock | 2021-10-13 | P | A | 15 | $2.71 | 5,769,594 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 10 | Common | Common Stock | 2021-10-14 | P | A | 15 | $2.81 | 5,769,609 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 11 | Common | Common Stock | 2021-10-15 | P | A | 15 | $2.76 | 5,769,624 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 12 | Common | Common Stock | 2021-10-18 | P | A | 15 | $2.75 | 5,769,639 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 13 | Common | Common Stock | 2021-10-19 | P | A | 15 | $2.76 | 5,769,654 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 14 | Common | Common Stock | 2021-10-20 | P | A | 15 | $2.63 | 5,769,669 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 15 | Common | Common Stock | 2021-10-21 | P | A | 15 | $2.65 | 5,769,684 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 16 | Common | Common Stock | 2021-10-22 | P | A | 15 | $2.66 | 5,769,699 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 17 | Common | Common Stock | 2021-10-25 | P | A | 15 | $2.64 | 5,769,714 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 18 | Common | Common Stock | 2021-10-26 | P | A | 15 | $2.64 | 5,769,729 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 19 | Common | Common Stock | 2021-10-27 | P | A | 15 | $2.61 | 5,769,744 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 20 | Common | Common Stock | 2021-10-28 | P | A | 15 | $2.61 | 5,769,759 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 21 | Common | Common Stock | 2021-10-29 | P | A | 15 | $2.72 | 5,769,774 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |